Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2? (2021)
Attributed to:
MICA: New combination therapy against MDR TB targeting the respiratory chain
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acsinfecdis.0c00478
PubMed Identifier: 33352056
Publication URI: http://europepmc.org/abstract/MED/33352056
Type: Journal Article/Review
Volume: 7
Parent Publication: ACS infectious diseases
Issue: 6
ISSN: 2373-8227